Bharat Biotech scales up Covaxin manufacturing capacity in India
The company will expand multiple facilities in Hyderabad and Bangalore to help reach its target of approximately 700 million doses per year of the COVID-19 vaccine
Indian vaccine maker Bharat Biotech has announced plans to expand its manufacturing capacity across multiple facilities at Hyderabad and Bangalore to produce approximately 700 million doses of its inactivated COVID-19 vaccine, Covaxin, annually.
The company says the availability of new specially designed biosafety level 3 (BSL-3) facilities will enable it to expand manufacturing capacity for the COVID-19 vaccine in a short timeline.
Compared with live virus vaccine production, manufacturing inactivated vaccines is more complex and expensive and results in lower yields.
According to Bloomberg, Bharat Biotech's scaling up announcement comes on the back of India’s government giving the firm a 650 million rupee ($8.7 million) grant last week. The timing of this cash boost comes as the country experiences a huge surge in COVID-19 cases.
The vaccine producer says raw materials, packing materials and single-use consumables for manufacturing have been secured to meet its capacity requirements.
To further increase capacities, Bharat Biotech has partnered with Indian Immunologicals to manufacture, at commercial scale, the drug substance for Covaxin, with the technology transfer process well underway.
In addition, the company is exploring manufacturing partnerships with partners in other countries, who have prior expertise with commercial-scale manufacture of inactivated viral vaccines under biosafety containment.
Bharat Biotech uses a proprietary adjuvant Algel-IMDG to stimulate memory T cell responses. The company said the synthesis and manufacture of the IMDG component has been successfully indigenised and will be manufactured at commercial scale within India, making this the first instance where a novel adjuvant has been commercialised in the country.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance